M., Martinoni B., Oberer L., Hommel U., Widmer H
better weight loss outcomes, better metabolic markers, fewer comorbidities) Reduced health costs in the long term by preventing complications (e.g
doi: 10.1016/j.gene.2017.09.016 39 DubeyBJacksonMZeigler-JohnsonCDevarajanKFlores-ObandoREMcFarlane-AndersonNet al
The article says GLP-1 agonists already slow gastric emptying and sharply reduce appetite, so many patients reach a caloric deficit without structured fasting
L-Carnitine has been characterized in the biochemical literature as the biologically active stereoisomer of the carnitine zwitterion pair, with the (R)-configuration at the C-3 hydroxyl center [1]
Relative risk of mortality and morbidity As per the non-diabetic model, but with benefits specific to the diabetic population